Eun‐Ji Choi

ORCID: 0000-0002-9568-8877 · 1 paper in corpus
observational 2018
·doi:10.1182/blood-2018-99-115931

Abstract Background Improvement of cytopenia is one of the primary treatment purposes for patients with the lower-risk myelodysplastic syndrome (MDS). Androgens have been used for the treatment of aplastic anemia, immune thrombocytopenia, a…